Medical Care
Global Herpes Simplex Virus Infections Market Research Report 2025
- Jun 28, 25
- ID: 346896
- Pages: 87
- Figures: 90
- Views: 8
The global market for Herpes Simplex Virus Infections was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Herpes Simplex Virus Infections is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Herpes Simplex Virus Infections is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Herpes Simplex Virus Infections in Hospital is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Herpes Simplex Virus Infections include Admedus Limited, Agenus Inc., Aicuris Anti-infective Cures Gmbh, Asahi Kasei Corporation, Chimerix Inc., Clinigen Group Plc, Daewoong Pharmaceutical Co., Ltd., F. Hoffmann-la Roche Ltd., Glaxosmithkline Plc, Maruho Co. Ltd., etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Herpes Simplex Virus Infections, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Herpes Simplex Virus Infections.
The Herpes Simplex Virus Infections market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Herpes Simplex Virus Infections market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Herpes Simplex Virus Infections companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Admedus Limited
Agenus Inc.
Aicuris Anti-infective Cures Gmbh
Asahi Kasei Corporation
Chimerix Inc.
Clinigen Group Plc
Daewoong Pharmaceutical Co., Ltd.
F. Hoffmann-la Roche Ltd.
Glaxosmithkline Plc
Maruho Co. Ltd.
Merck
Mylan
Novartis
Sanofi Pasteur
Teva Pharmaceutical Industries Ltd.
Segment by Type
General Treatment
Antiviral Therapy
Segment by Application
Hospital
Clinic
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Herpes Simplex Virus Infections company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
North American market for Herpes Simplex Virus Infections is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Herpes Simplex Virus Infections is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Herpes Simplex Virus Infections in Hospital is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Herpes Simplex Virus Infections include Admedus Limited, Agenus Inc., Aicuris Anti-infective Cures Gmbh, Asahi Kasei Corporation, Chimerix Inc., Clinigen Group Plc, Daewoong Pharmaceutical Co., Ltd., F. Hoffmann-la Roche Ltd., Glaxosmithkline Plc, Maruho Co. Ltd., etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Herpes Simplex Virus Infections, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Herpes Simplex Virus Infections.
The Herpes Simplex Virus Infections market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Herpes Simplex Virus Infections market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Herpes Simplex Virus Infections companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Admedus Limited
Agenus Inc.
Aicuris Anti-infective Cures Gmbh
Asahi Kasei Corporation
Chimerix Inc.
Clinigen Group Plc
Daewoong Pharmaceutical Co., Ltd.
F. Hoffmann-la Roche Ltd.
Glaxosmithkline Plc
Maruho Co. Ltd.
Merck
Mylan
Novartis
Sanofi Pasteur
Teva Pharmaceutical Industries Ltd.
Segment by Type
General Treatment
Antiviral Therapy
Segment by Application
Hospital
Clinic
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Herpes Simplex Virus Infections company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Herpes Simplex Virus Infections Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 General Treatment
1.2.3 Antiviral Therapy
1.3 Market by Application
1.3.1 Global Herpes Simplex Virus Infections Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Herpes Simplex Virus Infections Market Perspective (2020-2031)
2.2 Global Herpes Simplex Virus Infections Growth Trends by Region
2.2.1 Global Herpes Simplex Virus Infections Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Herpes Simplex Virus Infections Historic Market Size by Region (2020-2025)
2.2.3 Herpes Simplex Virus Infections Forecasted Market Size by Region (2026-2031)
2.3 Herpes Simplex Virus Infections Market Dynamics
2.3.1 Herpes Simplex Virus Infections Industry Trends
2.3.2 Herpes Simplex Virus Infections Market Drivers
2.3.3 Herpes Simplex Virus Infections Market Challenges
2.3.4 Herpes Simplex Virus Infections Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Herpes Simplex Virus Infections Players by Revenue
3.1.1 Global Top Herpes Simplex Virus Infections Players by Revenue (2020-2025)
3.1.2 Global Herpes Simplex Virus Infections Revenue Market Share by Players (2020-2025)
3.2 Global Herpes Simplex Virus Infections Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Herpes Simplex Virus Infections Revenue
3.4 Global Herpes Simplex Virus Infections Market Concentration Ratio
3.4.1 Global Herpes Simplex Virus Infections Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Herpes Simplex Virus Infections Revenue in 2024
3.5 Global Key Players of Herpes Simplex Virus Infections Head office and Area Served
3.6 Global Key Players of Herpes Simplex Virus Infections, Product and Application
3.7 Global Key Players of Herpes Simplex Virus Infections, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Herpes Simplex Virus Infections Breakdown Data by Type
4.1 Global Herpes Simplex Virus Infections Historic Market Size by Type (2020-2025)
4.2 Global Herpes Simplex Virus Infections Forecasted Market Size by Type (2026-2031)
5 Herpes Simplex Virus Infections Breakdown Data by Application
5.1 Global Herpes Simplex Virus Infections Historic Market Size by Application (2020-2025)
5.2 Global Herpes Simplex Virus Infections Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Herpes Simplex Virus Infections Market Size (2020-2031)
6.2 North America Herpes Simplex Virus Infections Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Herpes Simplex Virus Infections Market Size by Country (2020-2025)
6.4 North America Herpes Simplex Virus Infections Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Herpes Simplex Virus Infections Market Size (2020-2031)
7.2 Europe Herpes Simplex Virus Infections Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Herpes Simplex Virus Infections Market Size by Country (2020-2025)
7.4 Europe Herpes Simplex Virus Infections Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Herpes Simplex Virus Infections Market Size (2020-2031)
8.2 Asia-Pacific Herpes Simplex Virus Infections Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Herpes Simplex Virus Infections Market Size by Region (2020-2025)
8.4 Asia-Pacific Herpes Simplex Virus Infections Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Herpes Simplex Virus Infections Market Size (2020-2031)
9.2 Latin America Herpes Simplex Virus Infections Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Herpes Simplex Virus Infections Market Size by Country (2020-2025)
9.4 Latin America Herpes Simplex Virus Infections Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Herpes Simplex Virus Infections Market Size (2020-2031)
10.2 Middle East & Africa Herpes Simplex Virus Infections Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Herpes Simplex Virus Infections Market Size by Country (2020-2025)
10.4 Middle East & Africa Herpes Simplex Virus Infections Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Admedus Limited
11.1.1 Admedus Limited Company Details
11.1.2 Admedus Limited Business Overview
11.1.3 Admedus Limited Herpes Simplex Virus Infections Introduction
11.1.4 Admedus Limited Revenue in Herpes Simplex Virus Infections Business (2020-2025)
11.1.5 Admedus Limited Recent Development
11.2 Agenus Inc.
11.2.1 Agenus Inc. Company Details
11.2.2 Agenus Inc. Business Overview
11.2.3 Agenus Inc. Herpes Simplex Virus Infections Introduction
11.2.4 Agenus Inc. Revenue in Herpes Simplex Virus Infections Business (2020-2025)
11.2.5 Agenus Inc. Recent Development
11.3 Aicuris Anti-infective Cures Gmbh
11.3.1 Aicuris Anti-infective Cures Gmbh Company Details
11.3.2 Aicuris Anti-infective Cures Gmbh Business Overview
11.3.3 Aicuris Anti-infective Cures Gmbh Herpes Simplex Virus Infections Introduction
11.3.4 Aicuris Anti-infective Cures Gmbh Revenue in Herpes Simplex Virus Infections Business (2020-2025)
11.3.5 Aicuris Anti-infective Cures Gmbh Recent Development
11.4 Asahi Kasei Corporation
11.4.1 Asahi Kasei Corporation Company Details
11.4.2 Asahi Kasei Corporation Business Overview
11.4.3 Asahi Kasei Corporation Herpes Simplex Virus Infections Introduction
11.4.4 Asahi Kasei Corporation Revenue in Herpes Simplex Virus Infections Business (2020-2025)
11.4.5 Asahi Kasei Corporation Recent Development
11.5 Chimerix Inc.
11.5.1 Chimerix Inc. Company Details
11.5.2 Chimerix Inc. Business Overview
11.5.3 Chimerix Inc. Herpes Simplex Virus Infections Introduction
11.5.4 Chimerix Inc. Revenue in Herpes Simplex Virus Infections Business (2020-2025)
11.5.5 Chimerix Inc. Recent Development
11.6 Clinigen Group Plc
11.6.1 Clinigen Group Plc Company Details
11.6.2 Clinigen Group Plc Business Overview
11.6.3 Clinigen Group Plc Herpes Simplex Virus Infections Introduction
11.6.4 Clinigen Group Plc Revenue in Herpes Simplex Virus Infections Business (2020-2025)
11.6.5 Clinigen Group Plc Recent Development
11.7 Daewoong Pharmaceutical Co., Ltd.
11.7.1 Daewoong Pharmaceutical Co., Ltd. Company Details
11.7.2 Daewoong Pharmaceutical Co., Ltd. Business Overview
11.7.3 Daewoong Pharmaceutical Co., Ltd. Herpes Simplex Virus Infections Introduction
11.7.4 Daewoong Pharmaceutical Co., Ltd. Revenue in Herpes Simplex Virus Infections Business (2020-2025)
11.7.5 Daewoong Pharmaceutical Co., Ltd. Recent Development
11.8 F. Hoffmann-la Roche Ltd.
11.8.1 F. Hoffmann-la Roche Ltd. Company Details
11.8.2 F. Hoffmann-la Roche Ltd. Business Overview
11.8.3 F. Hoffmann-la Roche Ltd. Herpes Simplex Virus Infections Introduction
11.8.4 F. Hoffmann-la Roche Ltd. Revenue in Herpes Simplex Virus Infections Business (2020-2025)
11.8.5 F. Hoffmann-la Roche Ltd. Recent Development
11.9 Glaxosmithkline Plc
11.9.1 Glaxosmithkline Plc Company Details
11.9.2 Glaxosmithkline Plc Business Overview
11.9.3 Glaxosmithkline Plc Herpes Simplex Virus Infections Introduction
11.9.4 Glaxosmithkline Plc Revenue in Herpes Simplex Virus Infections Business (2020-2025)
11.9.5 Glaxosmithkline Plc Recent Development
11.10 Maruho Co. Ltd.
11.10.1 Maruho Co. Ltd. Company Details
11.10.2 Maruho Co. Ltd. Business Overview
11.10.3 Maruho Co. Ltd. Herpes Simplex Virus Infections Introduction
11.10.4 Maruho Co. Ltd. Revenue in Herpes Simplex Virus Infections Business (2020-2025)
11.10.5 Maruho Co. Ltd. Recent Development
11.11 Merck
11.11.1 Merck Company Details
11.11.2 Merck Business Overview
11.11.3 Merck Herpes Simplex Virus Infections Introduction
11.11.4 Merck Revenue in Herpes Simplex Virus Infections Business (2020-2025)
11.11.5 Merck Recent Development
11.12 Mylan
11.12.1 Mylan Company Details
11.12.2 Mylan Business Overview
11.12.3 Mylan Herpes Simplex Virus Infections Introduction
11.12.4 Mylan Revenue in Herpes Simplex Virus Infections Business (2020-2025)
11.12.5 Mylan Recent Development
11.13 Novartis
11.13.1 Novartis Company Details
11.13.2 Novartis Business Overview
11.13.3 Novartis Herpes Simplex Virus Infections Introduction
11.13.4 Novartis Revenue in Herpes Simplex Virus Infections Business (2020-2025)
11.13.5 Novartis Recent Development
11.14 Sanofi Pasteur
11.14.1 Sanofi Pasteur Company Details
11.14.2 Sanofi Pasteur Business Overview
11.14.3 Sanofi Pasteur Herpes Simplex Virus Infections Introduction
11.14.4 Sanofi Pasteur Revenue in Herpes Simplex Virus Infections Business (2020-2025)
11.14.5 Sanofi Pasteur Recent Development
11.15 Teva Pharmaceutical Industries Ltd.
11.15.1 Teva Pharmaceutical Industries Ltd. Company Details
11.15.2 Teva Pharmaceutical Industries Ltd. Business Overview
11.15.3 Teva Pharmaceutical Industries Ltd. Herpes Simplex Virus Infections Introduction
11.15.4 Teva Pharmaceutical Industries Ltd. Revenue in Herpes Simplex Virus Infections Business (2020-2025)
11.15.5 Teva Pharmaceutical Industries Ltd. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Herpes Simplex Virus Infections Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 General Treatment
1.2.3 Antiviral Therapy
1.3 Market by Application
1.3.1 Global Herpes Simplex Virus Infections Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Herpes Simplex Virus Infections Market Perspective (2020-2031)
2.2 Global Herpes Simplex Virus Infections Growth Trends by Region
2.2.1 Global Herpes Simplex Virus Infections Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Herpes Simplex Virus Infections Historic Market Size by Region (2020-2025)
2.2.3 Herpes Simplex Virus Infections Forecasted Market Size by Region (2026-2031)
2.3 Herpes Simplex Virus Infections Market Dynamics
2.3.1 Herpes Simplex Virus Infections Industry Trends
2.3.2 Herpes Simplex Virus Infections Market Drivers
2.3.3 Herpes Simplex Virus Infections Market Challenges
2.3.4 Herpes Simplex Virus Infections Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Herpes Simplex Virus Infections Players by Revenue
3.1.1 Global Top Herpes Simplex Virus Infections Players by Revenue (2020-2025)
3.1.2 Global Herpes Simplex Virus Infections Revenue Market Share by Players (2020-2025)
3.2 Global Herpes Simplex Virus Infections Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Herpes Simplex Virus Infections Revenue
3.4 Global Herpes Simplex Virus Infections Market Concentration Ratio
3.4.1 Global Herpes Simplex Virus Infections Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Herpes Simplex Virus Infections Revenue in 2024
3.5 Global Key Players of Herpes Simplex Virus Infections Head office and Area Served
3.6 Global Key Players of Herpes Simplex Virus Infections, Product and Application
3.7 Global Key Players of Herpes Simplex Virus Infections, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Herpes Simplex Virus Infections Breakdown Data by Type
4.1 Global Herpes Simplex Virus Infections Historic Market Size by Type (2020-2025)
4.2 Global Herpes Simplex Virus Infections Forecasted Market Size by Type (2026-2031)
5 Herpes Simplex Virus Infections Breakdown Data by Application
5.1 Global Herpes Simplex Virus Infections Historic Market Size by Application (2020-2025)
5.2 Global Herpes Simplex Virus Infections Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Herpes Simplex Virus Infections Market Size (2020-2031)
6.2 North America Herpes Simplex Virus Infections Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Herpes Simplex Virus Infections Market Size by Country (2020-2025)
6.4 North America Herpes Simplex Virus Infections Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Herpes Simplex Virus Infections Market Size (2020-2031)
7.2 Europe Herpes Simplex Virus Infections Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Herpes Simplex Virus Infections Market Size by Country (2020-2025)
7.4 Europe Herpes Simplex Virus Infections Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Herpes Simplex Virus Infections Market Size (2020-2031)
8.2 Asia-Pacific Herpes Simplex Virus Infections Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Herpes Simplex Virus Infections Market Size by Region (2020-2025)
8.4 Asia-Pacific Herpes Simplex Virus Infections Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Herpes Simplex Virus Infections Market Size (2020-2031)
9.2 Latin America Herpes Simplex Virus Infections Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Herpes Simplex Virus Infections Market Size by Country (2020-2025)
9.4 Latin America Herpes Simplex Virus Infections Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Herpes Simplex Virus Infections Market Size (2020-2031)
10.2 Middle East & Africa Herpes Simplex Virus Infections Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Herpes Simplex Virus Infections Market Size by Country (2020-2025)
10.4 Middle East & Africa Herpes Simplex Virus Infections Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Admedus Limited
11.1.1 Admedus Limited Company Details
11.1.2 Admedus Limited Business Overview
11.1.3 Admedus Limited Herpes Simplex Virus Infections Introduction
11.1.4 Admedus Limited Revenue in Herpes Simplex Virus Infections Business (2020-2025)
11.1.5 Admedus Limited Recent Development
11.2 Agenus Inc.
11.2.1 Agenus Inc. Company Details
11.2.2 Agenus Inc. Business Overview
11.2.3 Agenus Inc. Herpes Simplex Virus Infections Introduction
11.2.4 Agenus Inc. Revenue in Herpes Simplex Virus Infections Business (2020-2025)
11.2.5 Agenus Inc. Recent Development
11.3 Aicuris Anti-infective Cures Gmbh
11.3.1 Aicuris Anti-infective Cures Gmbh Company Details
11.3.2 Aicuris Anti-infective Cures Gmbh Business Overview
11.3.3 Aicuris Anti-infective Cures Gmbh Herpes Simplex Virus Infections Introduction
11.3.4 Aicuris Anti-infective Cures Gmbh Revenue in Herpes Simplex Virus Infections Business (2020-2025)
11.3.5 Aicuris Anti-infective Cures Gmbh Recent Development
11.4 Asahi Kasei Corporation
11.4.1 Asahi Kasei Corporation Company Details
11.4.2 Asahi Kasei Corporation Business Overview
11.4.3 Asahi Kasei Corporation Herpes Simplex Virus Infections Introduction
11.4.4 Asahi Kasei Corporation Revenue in Herpes Simplex Virus Infections Business (2020-2025)
11.4.5 Asahi Kasei Corporation Recent Development
11.5 Chimerix Inc.
11.5.1 Chimerix Inc. Company Details
11.5.2 Chimerix Inc. Business Overview
11.5.3 Chimerix Inc. Herpes Simplex Virus Infections Introduction
11.5.4 Chimerix Inc. Revenue in Herpes Simplex Virus Infections Business (2020-2025)
11.5.5 Chimerix Inc. Recent Development
11.6 Clinigen Group Plc
11.6.1 Clinigen Group Plc Company Details
11.6.2 Clinigen Group Plc Business Overview
11.6.3 Clinigen Group Plc Herpes Simplex Virus Infections Introduction
11.6.4 Clinigen Group Plc Revenue in Herpes Simplex Virus Infections Business (2020-2025)
11.6.5 Clinigen Group Plc Recent Development
11.7 Daewoong Pharmaceutical Co., Ltd.
11.7.1 Daewoong Pharmaceutical Co., Ltd. Company Details
11.7.2 Daewoong Pharmaceutical Co., Ltd. Business Overview
11.7.3 Daewoong Pharmaceutical Co., Ltd. Herpes Simplex Virus Infections Introduction
11.7.4 Daewoong Pharmaceutical Co., Ltd. Revenue in Herpes Simplex Virus Infections Business (2020-2025)
11.7.5 Daewoong Pharmaceutical Co., Ltd. Recent Development
11.8 F. Hoffmann-la Roche Ltd.
11.8.1 F. Hoffmann-la Roche Ltd. Company Details
11.8.2 F. Hoffmann-la Roche Ltd. Business Overview
11.8.3 F. Hoffmann-la Roche Ltd. Herpes Simplex Virus Infections Introduction
11.8.4 F. Hoffmann-la Roche Ltd. Revenue in Herpes Simplex Virus Infections Business (2020-2025)
11.8.5 F. Hoffmann-la Roche Ltd. Recent Development
11.9 Glaxosmithkline Plc
11.9.1 Glaxosmithkline Plc Company Details
11.9.2 Glaxosmithkline Plc Business Overview
11.9.3 Glaxosmithkline Plc Herpes Simplex Virus Infections Introduction
11.9.4 Glaxosmithkline Plc Revenue in Herpes Simplex Virus Infections Business (2020-2025)
11.9.5 Glaxosmithkline Plc Recent Development
11.10 Maruho Co. Ltd.
11.10.1 Maruho Co. Ltd. Company Details
11.10.2 Maruho Co. Ltd. Business Overview
11.10.3 Maruho Co. Ltd. Herpes Simplex Virus Infections Introduction
11.10.4 Maruho Co. Ltd. Revenue in Herpes Simplex Virus Infections Business (2020-2025)
11.10.5 Maruho Co. Ltd. Recent Development
11.11 Merck
11.11.1 Merck Company Details
11.11.2 Merck Business Overview
11.11.3 Merck Herpes Simplex Virus Infections Introduction
11.11.4 Merck Revenue in Herpes Simplex Virus Infections Business (2020-2025)
11.11.5 Merck Recent Development
11.12 Mylan
11.12.1 Mylan Company Details
11.12.2 Mylan Business Overview
11.12.3 Mylan Herpes Simplex Virus Infections Introduction
11.12.4 Mylan Revenue in Herpes Simplex Virus Infections Business (2020-2025)
11.12.5 Mylan Recent Development
11.13 Novartis
11.13.1 Novartis Company Details
11.13.2 Novartis Business Overview
11.13.3 Novartis Herpes Simplex Virus Infections Introduction
11.13.4 Novartis Revenue in Herpes Simplex Virus Infections Business (2020-2025)
11.13.5 Novartis Recent Development
11.14 Sanofi Pasteur
11.14.1 Sanofi Pasteur Company Details
11.14.2 Sanofi Pasteur Business Overview
11.14.3 Sanofi Pasteur Herpes Simplex Virus Infections Introduction
11.14.4 Sanofi Pasteur Revenue in Herpes Simplex Virus Infections Business (2020-2025)
11.14.5 Sanofi Pasteur Recent Development
11.15 Teva Pharmaceutical Industries Ltd.
11.15.1 Teva Pharmaceutical Industries Ltd. Company Details
11.15.2 Teva Pharmaceutical Industries Ltd. Business Overview
11.15.3 Teva Pharmaceutical Industries Ltd. Herpes Simplex Virus Infections Introduction
11.15.4 Teva Pharmaceutical Industries Ltd. Revenue in Herpes Simplex Virus Infections Business (2020-2025)
11.15.5 Teva Pharmaceutical Industries Ltd. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Herpes Simplex Virus Infections Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of General Treatment
Table 3. Key Players of Antiviral Therapy
Table 4. Global Herpes Simplex Virus Infections Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Herpes Simplex Virus Infections Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Herpes Simplex Virus Infections Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Herpes Simplex Virus Infections Market Share by Region (2020-2025)
Table 8. Global Herpes Simplex Virus Infections Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Herpes Simplex Virus Infections Market Share by Region (2026-2031)
Table 10. Herpes Simplex Virus Infections Market Trends
Table 11. Herpes Simplex Virus Infections Market Drivers
Table 12. Herpes Simplex Virus Infections Market Challenges
Table 13. Herpes Simplex Virus Infections Market Restraints
Table 14. Global Herpes Simplex Virus Infections Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Herpes Simplex Virus Infections Market Share by Players (2020-2025)
Table 16. Global Top Herpes Simplex Virus Infections Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Herpes Simplex Virus Infections as of 2024)
Table 17. Ranking of Global Top Herpes Simplex Virus Infections Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Herpes Simplex Virus Infections Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Herpes Simplex Virus Infections, Headquarters and Area Served
Table 20. Global Key Players of Herpes Simplex Virus Infections, Product and Application
Table 21. Global Key Players of Herpes Simplex Virus Infections, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Herpes Simplex Virus Infections Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Herpes Simplex Virus Infections Revenue Market Share by Type (2020-2025)
Table 25. Global Herpes Simplex Virus Infections Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Herpes Simplex Virus Infections Revenue Market Share by Type (2026-2031)
Table 27. Global Herpes Simplex Virus Infections Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Herpes Simplex Virus Infections Revenue Market Share by Application (2020-2025)
Table 29. Global Herpes Simplex Virus Infections Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Herpes Simplex Virus Infections Revenue Market Share by Application (2026-2031)
Table 31. North America Herpes Simplex Virus Infections Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Herpes Simplex Virus Infections Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Herpes Simplex Virus Infections Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Herpes Simplex Virus Infections Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Herpes Simplex Virus Infections Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Herpes Simplex Virus Infections Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Herpes Simplex Virus Infections Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Herpes Simplex Virus Infections Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Herpes Simplex Virus Infections Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Herpes Simplex Virus Infections Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Herpes Simplex Virus Infections Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Herpes Simplex Virus Infections Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Herpes Simplex Virus Infections Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Herpes Simplex Virus Infections Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Herpes Simplex Virus Infections Market Size by Country (2026-2031) & (US$ Million)
Table 46. Admedus Limited Company Details
Table 47. Admedus Limited Business Overview
Table 48. Admedus Limited Herpes Simplex Virus Infections Product
Table 49. Admedus Limited Revenue in Herpes Simplex Virus Infections Business (2020-2025) & (US$ Million)
Table 50. Admedus Limited Recent Development
Table 51. Agenus Inc. Company Details
Table 52. Agenus Inc. Business Overview
Table 53. Agenus Inc. Herpes Simplex Virus Infections Product
Table 54. Agenus Inc. Revenue in Herpes Simplex Virus Infections Business (2020-2025) & (US$ Million)
Table 55. Agenus Inc. Recent Development
Table 56. Aicuris Anti-infective Cures Gmbh Company Details
Table 57. Aicuris Anti-infective Cures Gmbh Business Overview
Table 58. Aicuris Anti-infective Cures Gmbh Herpes Simplex Virus Infections Product
Table 59. Aicuris Anti-infective Cures Gmbh Revenue in Herpes Simplex Virus Infections Business (2020-2025) & (US$ Million)
Table 60. Aicuris Anti-infective Cures Gmbh Recent Development
Table 61. Asahi Kasei Corporation Company Details
Table 62. Asahi Kasei Corporation Business Overview
Table 63. Asahi Kasei Corporation Herpes Simplex Virus Infections Product
Table 64. Asahi Kasei Corporation Revenue in Herpes Simplex Virus Infections Business (2020-2025) & (US$ Million)
Table 65. Asahi Kasei Corporation Recent Development
Table 66. Chimerix Inc. Company Details
Table 67. Chimerix Inc. Business Overview
Table 68. Chimerix Inc. Herpes Simplex Virus Infections Product
Table 69. Chimerix Inc. Revenue in Herpes Simplex Virus Infections Business (2020-2025) & (US$ Million)
Table 70. Chimerix Inc. Recent Development
Table 71. Clinigen Group Plc Company Details
Table 72. Clinigen Group Plc Business Overview
Table 73. Clinigen Group Plc Herpes Simplex Virus Infections Product
Table 74. Clinigen Group Plc Revenue in Herpes Simplex Virus Infections Business (2020-2025) & (US$ Million)
Table 75. Clinigen Group Plc Recent Development
Table 76. Daewoong Pharmaceutical Co., Ltd. Company Details
Table 77. Daewoong Pharmaceutical Co., Ltd. Business Overview
Table 78. Daewoong Pharmaceutical Co., Ltd. Herpes Simplex Virus Infections Product
Table 79. Daewoong Pharmaceutical Co., Ltd. Revenue in Herpes Simplex Virus Infections Business (2020-2025) & (US$ Million)
Table 80. Daewoong Pharmaceutical Co., Ltd. Recent Development
Table 81. F. Hoffmann-la Roche Ltd. Company Details
Table 82. F. Hoffmann-la Roche Ltd. Business Overview
Table 83. F. Hoffmann-la Roche Ltd. Herpes Simplex Virus Infections Product
Table 84. F. Hoffmann-la Roche Ltd. Revenue in Herpes Simplex Virus Infections Business (2020-2025) & (US$ Million)
Table 85. F. Hoffmann-la Roche Ltd. Recent Development
Table 86. Glaxosmithkline Plc Company Details
Table 87. Glaxosmithkline Plc Business Overview
Table 88. Glaxosmithkline Plc Herpes Simplex Virus Infections Product
Table 89. Glaxosmithkline Plc Revenue in Herpes Simplex Virus Infections Business (2020-2025) & (US$ Million)
Table 90. Glaxosmithkline Plc Recent Development
Table 91. Maruho Co. Ltd. Company Details
Table 92. Maruho Co. Ltd. Business Overview
Table 93. Maruho Co. Ltd. Herpes Simplex Virus Infections Product
Table 94. Maruho Co. Ltd. Revenue in Herpes Simplex Virus Infections Business (2020-2025) & (US$ Million)
Table 95. Maruho Co. Ltd. Recent Development
Table 96. Merck Company Details
Table 97. Merck Business Overview
Table 98. Merck Herpes Simplex Virus Infections Product
Table 99. Merck Revenue in Herpes Simplex Virus Infections Business (2020-2025) & (US$ Million)
Table 100. Merck Recent Development
Table 101. Mylan Company Details
Table 102. Mylan Business Overview
Table 103. Mylan Herpes Simplex Virus Infections Product
Table 104. Mylan Revenue in Herpes Simplex Virus Infections Business (2020-2025) & (US$ Million)
Table 105. Mylan Recent Development
Table 106. Novartis Company Details
Table 107. Novartis Business Overview
Table 108. Novartis Herpes Simplex Virus Infections Product
Table 109. Novartis Revenue in Herpes Simplex Virus Infections Business (2020-2025) & (US$ Million)
Table 110. Novartis Recent Development
Table 111. Sanofi Pasteur Company Details
Table 112. Sanofi Pasteur Business Overview
Table 113. Sanofi Pasteur Herpes Simplex Virus Infections Product
Table 114. Sanofi Pasteur Revenue in Herpes Simplex Virus Infections Business (2020-2025) & (US$ Million)
Table 115. Sanofi Pasteur Recent Development
Table 116. Teva Pharmaceutical Industries Ltd. Company Details
Table 117. Teva Pharmaceutical Industries Ltd. Business Overview
Table 118. Teva Pharmaceutical Industries Ltd. Herpes Simplex Virus Infections Product
Table 119. Teva Pharmaceutical Industries Ltd. Revenue in Herpes Simplex Virus Infections Business (2020-2025) & (US$ Million)
Table 120. Teva Pharmaceutical Industries Ltd. Recent Development
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
Table 124. Authors List of This Report
List of Figures
Figure 1. Herpes Simplex Virus Infections Picture
Figure 2. Global Herpes Simplex Virus Infections Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Herpes Simplex Virus Infections Market Share by Type: 2024 VS 2031
Figure 4. General Treatment Features
Figure 5. Antiviral Therapy Features
Figure 6. Global Herpes Simplex Virus Infections Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Herpes Simplex Virus Infections Market Share by Application: 2024 VS 2031
Figure 8. Hospital Case Studies
Figure 9. Clinic Case Studies
Figure 10. Other Case Studies
Figure 11. Herpes Simplex Virus Infections Report Years Considered
Figure 12. Global Herpes Simplex Virus Infections Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Herpes Simplex Virus Infections Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Herpes Simplex Virus Infections Market Share by Region: 2024 VS 2031
Figure 15. Global Herpes Simplex Virus Infections Market Share by Players in 2024
Figure 16. Global Top Herpes Simplex Virus Infections Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Herpes Simplex Virus Infections as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Herpes Simplex Virus Infections Revenue in 2024
Figure 18. North America Herpes Simplex Virus Infections Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Herpes Simplex Virus Infections Market Share by Country (2020-2031)
Figure 20. United States Herpes Simplex Virus Infections Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Herpes Simplex Virus Infections Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Herpes Simplex Virus Infections Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Herpes Simplex Virus Infections Market Share by Country (2020-2031)
Figure 24. Germany Herpes Simplex Virus Infections Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Herpes Simplex Virus Infections Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Herpes Simplex Virus Infections Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Herpes Simplex Virus Infections Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Herpes Simplex Virus Infections Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Herpes Simplex Virus Infections Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Herpes Simplex Virus Infections Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Herpes Simplex Virus Infections Market Share by Region (2020-2031)
Figure 32. China Herpes Simplex Virus Infections Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Herpes Simplex Virus Infections Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Herpes Simplex Virus Infections Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Herpes Simplex Virus Infections Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Herpes Simplex Virus Infections Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Herpes Simplex Virus Infections Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Herpes Simplex Virus Infections Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Herpes Simplex Virus Infections Market Share by Country (2020-2031)
Figure 40. Mexico Herpes Simplex Virus Infections Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Herpes Simplex Virus Infections Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Herpes Simplex Virus Infections Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Herpes Simplex Virus Infections Market Share by Country (2020-2031)
Figure 44. Turkey Herpes Simplex Virus Infections Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Herpes Simplex Virus Infections Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Herpes Simplex Virus Infections Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Admedus Limited Revenue Growth Rate in Herpes Simplex Virus Infections Business (2020-2025)
Figure 48. Agenus Inc. Revenue Growth Rate in Herpes Simplex Virus Infections Business (2020-2025)
Figure 49. Aicuris Anti-infective Cures Gmbh Revenue Growth Rate in Herpes Simplex Virus Infections Business (2020-2025)
Figure 50. Asahi Kasei Corporation Revenue Growth Rate in Herpes Simplex Virus Infections Business (2020-2025)
Figure 51. Chimerix Inc. Revenue Growth Rate in Herpes Simplex Virus Infections Business (2020-2025)
Figure 52. Clinigen Group Plc Revenue Growth Rate in Herpes Simplex Virus Infections Business (2020-2025)
Figure 53. Daewoong Pharmaceutical Co., Ltd. Revenue Growth Rate in Herpes Simplex Virus Infections Business (2020-2025)
Figure 54. F. Hoffmann-la Roche Ltd. Revenue Growth Rate in Herpes Simplex Virus Infections Business (2020-2025)
Figure 55. Glaxosmithkline Plc Revenue Growth Rate in Herpes Simplex Virus Infections Business (2020-2025)
Figure 56. Maruho Co. Ltd. Revenue Growth Rate in Herpes Simplex Virus Infections Business (2020-2025)
Figure 57. Merck Revenue Growth Rate in Herpes Simplex Virus Infections Business (2020-2025)
Figure 58. Mylan Revenue Growth Rate in Herpes Simplex Virus Infections Business (2020-2025)
Figure 59. Novartis Revenue Growth Rate in Herpes Simplex Virus Infections Business (2020-2025)
Figure 60. Sanofi Pasteur Revenue Growth Rate in Herpes Simplex Virus Infections Business (2020-2025)
Figure 61. Teva Pharmaceutical Industries Ltd. Revenue Growth Rate in Herpes Simplex Virus Infections Business (2020-2025)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Table 1. Global Herpes Simplex Virus Infections Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of General Treatment
Table 3. Key Players of Antiviral Therapy
Table 4. Global Herpes Simplex Virus Infections Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Herpes Simplex Virus Infections Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Herpes Simplex Virus Infections Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Herpes Simplex Virus Infections Market Share by Region (2020-2025)
Table 8. Global Herpes Simplex Virus Infections Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Herpes Simplex Virus Infections Market Share by Region (2026-2031)
Table 10. Herpes Simplex Virus Infections Market Trends
Table 11. Herpes Simplex Virus Infections Market Drivers
Table 12. Herpes Simplex Virus Infections Market Challenges
Table 13. Herpes Simplex Virus Infections Market Restraints
Table 14. Global Herpes Simplex Virus Infections Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Herpes Simplex Virus Infections Market Share by Players (2020-2025)
Table 16. Global Top Herpes Simplex Virus Infections Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Herpes Simplex Virus Infections as of 2024)
Table 17. Ranking of Global Top Herpes Simplex Virus Infections Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Herpes Simplex Virus Infections Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Herpes Simplex Virus Infections, Headquarters and Area Served
Table 20. Global Key Players of Herpes Simplex Virus Infections, Product and Application
Table 21. Global Key Players of Herpes Simplex Virus Infections, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Herpes Simplex Virus Infections Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Herpes Simplex Virus Infections Revenue Market Share by Type (2020-2025)
Table 25. Global Herpes Simplex Virus Infections Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Herpes Simplex Virus Infections Revenue Market Share by Type (2026-2031)
Table 27. Global Herpes Simplex Virus Infections Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Herpes Simplex Virus Infections Revenue Market Share by Application (2020-2025)
Table 29. Global Herpes Simplex Virus Infections Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Herpes Simplex Virus Infections Revenue Market Share by Application (2026-2031)
Table 31. North America Herpes Simplex Virus Infections Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Herpes Simplex Virus Infections Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Herpes Simplex Virus Infections Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Herpes Simplex Virus Infections Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Herpes Simplex Virus Infections Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Herpes Simplex Virus Infections Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Herpes Simplex Virus Infections Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Herpes Simplex Virus Infections Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Herpes Simplex Virus Infections Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Herpes Simplex Virus Infections Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Herpes Simplex Virus Infections Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Herpes Simplex Virus Infections Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Herpes Simplex Virus Infections Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Herpes Simplex Virus Infections Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Herpes Simplex Virus Infections Market Size by Country (2026-2031) & (US$ Million)
Table 46. Admedus Limited Company Details
Table 47. Admedus Limited Business Overview
Table 48. Admedus Limited Herpes Simplex Virus Infections Product
Table 49. Admedus Limited Revenue in Herpes Simplex Virus Infections Business (2020-2025) & (US$ Million)
Table 50. Admedus Limited Recent Development
Table 51. Agenus Inc. Company Details
Table 52. Agenus Inc. Business Overview
Table 53. Agenus Inc. Herpes Simplex Virus Infections Product
Table 54. Agenus Inc. Revenue in Herpes Simplex Virus Infections Business (2020-2025) & (US$ Million)
Table 55. Agenus Inc. Recent Development
Table 56. Aicuris Anti-infective Cures Gmbh Company Details
Table 57. Aicuris Anti-infective Cures Gmbh Business Overview
Table 58. Aicuris Anti-infective Cures Gmbh Herpes Simplex Virus Infections Product
Table 59. Aicuris Anti-infective Cures Gmbh Revenue in Herpes Simplex Virus Infections Business (2020-2025) & (US$ Million)
Table 60. Aicuris Anti-infective Cures Gmbh Recent Development
Table 61. Asahi Kasei Corporation Company Details
Table 62. Asahi Kasei Corporation Business Overview
Table 63. Asahi Kasei Corporation Herpes Simplex Virus Infections Product
Table 64. Asahi Kasei Corporation Revenue in Herpes Simplex Virus Infections Business (2020-2025) & (US$ Million)
Table 65. Asahi Kasei Corporation Recent Development
Table 66. Chimerix Inc. Company Details
Table 67. Chimerix Inc. Business Overview
Table 68. Chimerix Inc. Herpes Simplex Virus Infections Product
Table 69. Chimerix Inc. Revenue in Herpes Simplex Virus Infections Business (2020-2025) & (US$ Million)
Table 70. Chimerix Inc. Recent Development
Table 71. Clinigen Group Plc Company Details
Table 72. Clinigen Group Plc Business Overview
Table 73. Clinigen Group Plc Herpes Simplex Virus Infections Product
Table 74. Clinigen Group Plc Revenue in Herpes Simplex Virus Infections Business (2020-2025) & (US$ Million)
Table 75. Clinigen Group Plc Recent Development
Table 76. Daewoong Pharmaceutical Co., Ltd. Company Details
Table 77. Daewoong Pharmaceutical Co., Ltd. Business Overview
Table 78. Daewoong Pharmaceutical Co., Ltd. Herpes Simplex Virus Infections Product
Table 79. Daewoong Pharmaceutical Co., Ltd. Revenue in Herpes Simplex Virus Infections Business (2020-2025) & (US$ Million)
Table 80. Daewoong Pharmaceutical Co., Ltd. Recent Development
Table 81. F. Hoffmann-la Roche Ltd. Company Details
Table 82. F. Hoffmann-la Roche Ltd. Business Overview
Table 83. F. Hoffmann-la Roche Ltd. Herpes Simplex Virus Infections Product
Table 84. F. Hoffmann-la Roche Ltd. Revenue in Herpes Simplex Virus Infections Business (2020-2025) & (US$ Million)
Table 85. F. Hoffmann-la Roche Ltd. Recent Development
Table 86. Glaxosmithkline Plc Company Details
Table 87. Glaxosmithkline Plc Business Overview
Table 88. Glaxosmithkline Plc Herpes Simplex Virus Infections Product
Table 89. Glaxosmithkline Plc Revenue in Herpes Simplex Virus Infections Business (2020-2025) & (US$ Million)
Table 90. Glaxosmithkline Plc Recent Development
Table 91. Maruho Co. Ltd. Company Details
Table 92. Maruho Co. Ltd. Business Overview
Table 93. Maruho Co. Ltd. Herpes Simplex Virus Infections Product
Table 94. Maruho Co. Ltd. Revenue in Herpes Simplex Virus Infections Business (2020-2025) & (US$ Million)
Table 95. Maruho Co. Ltd. Recent Development
Table 96. Merck Company Details
Table 97. Merck Business Overview
Table 98. Merck Herpes Simplex Virus Infections Product
Table 99. Merck Revenue in Herpes Simplex Virus Infections Business (2020-2025) & (US$ Million)
Table 100. Merck Recent Development
Table 101. Mylan Company Details
Table 102. Mylan Business Overview
Table 103. Mylan Herpes Simplex Virus Infections Product
Table 104. Mylan Revenue in Herpes Simplex Virus Infections Business (2020-2025) & (US$ Million)
Table 105. Mylan Recent Development
Table 106. Novartis Company Details
Table 107. Novartis Business Overview
Table 108. Novartis Herpes Simplex Virus Infections Product
Table 109. Novartis Revenue in Herpes Simplex Virus Infections Business (2020-2025) & (US$ Million)
Table 110. Novartis Recent Development
Table 111. Sanofi Pasteur Company Details
Table 112. Sanofi Pasteur Business Overview
Table 113. Sanofi Pasteur Herpes Simplex Virus Infections Product
Table 114. Sanofi Pasteur Revenue in Herpes Simplex Virus Infections Business (2020-2025) & (US$ Million)
Table 115. Sanofi Pasteur Recent Development
Table 116. Teva Pharmaceutical Industries Ltd. Company Details
Table 117. Teva Pharmaceutical Industries Ltd. Business Overview
Table 118. Teva Pharmaceutical Industries Ltd. Herpes Simplex Virus Infections Product
Table 119. Teva Pharmaceutical Industries Ltd. Revenue in Herpes Simplex Virus Infections Business (2020-2025) & (US$ Million)
Table 120. Teva Pharmaceutical Industries Ltd. Recent Development
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
Table 124. Authors List of This Report
List of Figures
Figure 1. Herpes Simplex Virus Infections Picture
Figure 2. Global Herpes Simplex Virus Infections Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Herpes Simplex Virus Infections Market Share by Type: 2024 VS 2031
Figure 4. General Treatment Features
Figure 5. Antiviral Therapy Features
Figure 6. Global Herpes Simplex Virus Infections Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Herpes Simplex Virus Infections Market Share by Application: 2024 VS 2031
Figure 8. Hospital Case Studies
Figure 9. Clinic Case Studies
Figure 10. Other Case Studies
Figure 11. Herpes Simplex Virus Infections Report Years Considered
Figure 12. Global Herpes Simplex Virus Infections Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Herpes Simplex Virus Infections Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Herpes Simplex Virus Infections Market Share by Region: 2024 VS 2031
Figure 15. Global Herpes Simplex Virus Infections Market Share by Players in 2024
Figure 16. Global Top Herpes Simplex Virus Infections Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Herpes Simplex Virus Infections as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Herpes Simplex Virus Infections Revenue in 2024
Figure 18. North America Herpes Simplex Virus Infections Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Herpes Simplex Virus Infections Market Share by Country (2020-2031)
Figure 20. United States Herpes Simplex Virus Infections Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Herpes Simplex Virus Infections Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Herpes Simplex Virus Infections Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Herpes Simplex Virus Infections Market Share by Country (2020-2031)
Figure 24. Germany Herpes Simplex Virus Infections Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Herpes Simplex Virus Infections Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Herpes Simplex Virus Infections Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Herpes Simplex Virus Infections Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Herpes Simplex Virus Infections Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Herpes Simplex Virus Infections Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Herpes Simplex Virus Infections Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Herpes Simplex Virus Infections Market Share by Region (2020-2031)
Figure 32. China Herpes Simplex Virus Infections Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Herpes Simplex Virus Infections Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Herpes Simplex Virus Infections Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Herpes Simplex Virus Infections Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Herpes Simplex Virus Infections Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Herpes Simplex Virus Infections Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Herpes Simplex Virus Infections Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Herpes Simplex Virus Infections Market Share by Country (2020-2031)
Figure 40. Mexico Herpes Simplex Virus Infections Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Herpes Simplex Virus Infections Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Herpes Simplex Virus Infections Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Herpes Simplex Virus Infections Market Share by Country (2020-2031)
Figure 44. Turkey Herpes Simplex Virus Infections Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Herpes Simplex Virus Infections Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Herpes Simplex Virus Infections Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Admedus Limited Revenue Growth Rate in Herpes Simplex Virus Infections Business (2020-2025)
Figure 48. Agenus Inc. Revenue Growth Rate in Herpes Simplex Virus Infections Business (2020-2025)
Figure 49. Aicuris Anti-infective Cures Gmbh Revenue Growth Rate in Herpes Simplex Virus Infections Business (2020-2025)
Figure 50. Asahi Kasei Corporation Revenue Growth Rate in Herpes Simplex Virus Infections Business (2020-2025)
Figure 51. Chimerix Inc. Revenue Growth Rate in Herpes Simplex Virus Infections Business (2020-2025)
Figure 52. Clinigen Group Plc Revenue Growth Rate in Herpes Simplex Virus Infections Business (2020-2025)
Figure 53. Daewoong Pharmaceutical Co., Ltd. Revenue Growth Rate in Herpes Simplex Virus Infections Business (2020-2025)
Figure 54. F. Hoffmann-la Roche Ltd. Revenue Growth Rate in Herpes Simplex Virus Infections Business (2020-2025)
Figure 55. Glaxosmithkline Plc Revenue Growth Rate in Herpes Simplex Virus Infections Business (2020-2025)
Figure 56. Maruho Co. Ltd. Revenue Growth Rate in Herpes Simplex Virus Infections Business (2020-2025)
Figure 57. Merck Revenue Growth Rate in Herpes Simplex Virus Infections Business (2020-2025)
Figure 58. Mylan Revenue Growth Rate in Herpes Simplex Virus Infections Business (2020-2025)
Figure 59. Novartis Revenue Growth Rate in Herpes Simplex Virus Infections Business (2020-2025)
Figure 60. Sanofi Pasteur Revenue Growth Rate in Herpes Simplex Virus Infections Business (2020-2025)
Figure 61. Teva Pharmaceutical Industries Ltd. Revenue Growth Rate in Herpes Simplex Virus Infections Business (2020-2025)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Allergen Detection Market Research Report 2025
Jun 28, 25
Global Electronic Health Tracking System Market Research Report 2025
Jun 28, 25
Global Speciality Optical Fibers Market Research Report 2025
Jun 28, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232